Cost Efficacy of Tazobactam/Piperacillin versus Imipenem/Cilastatin in the Treatment of Intra-Abdominal Infection

Author: Dietrich E.S.   Schubert B.   Ebner W.   Daschner F.  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.19, Iss.1, 2001-01, pp. : 79-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract